Industry: Medical Devices & Consumables
Published Date: 2026-04-17
Pages: 117 Pages
Report ld: 6473779
Request Sample
Customized Report
The global Atrial Septal Defect (ASD) Occluder market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Atrial Septal Defect (ASD) Occluder competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
The North American market for Atrial Septal Defect (ASD) Occluder is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Atrial Septal Defect (ASD) Occluder is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Atrial Septal Defect (ASD) Occluder include Gore Medical, Abbott, Lepu Medical, Lifetech, Occlutech, MicroPort Group, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Atrial Septal Defect (ASD) Occluder market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Atrial Septal Defect (ASD) Occluder. The Atrial Septal Defect (ASD) Occluder market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Atrial Septal Defect (ASD) Occluder market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Atrial Septal Defect (ASD) Occluder manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Atrial Septal Defect (ASD) Occluder manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Atrial Septal Defect (ASD) Occluder sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Atrial Septal Defect (ASD) Occluder Market Overview
1.1 Product Definition
1.2 Atrial Septal Defect (ASD) Occluder by Type
1.2.1 Global Atrial Septal Defect (ASD) Occluder Market Value by Type: 2025 vs 2032
1.2.2 16-32 mm Type
1.2.3 34-50 mm Type
1.3 Atrial Septal Defect (ASD) Occluder by Application
1.3.1 Global Atrial Septal Defect (ASD) Occluder Market Value by Application: 2025 vs 2032
1.3.2 Children
1.3.3 Adult
1.4 Global Atrial Septal Defect (ASD) Occluder Market Size Estimates and Forecasts
1.4.1 Global Atrial Septal Defect (ASD) Occluder Revenue 2021–2032
1.4.2 Global Atrial Septal Defect (ASD) Occluder Sales 2021–2032
1.4.3 Global Atrial Septal Defect (ASD) Occluder Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Atrial Septal Defect (ASD) Occluder Market Competition by Manufacturers
2.1 Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Manufacturers (2021–2026)
2.2 Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Atrial Septal Defect (ASD) Occluder Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Atrial Septal Defect (ASD) Occluder, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Product Types and Applications
2.7 Global Key Manufacturers of Atrial Septal Defect (ASD) Occluder, Date of Entry into the Industry
2.8 Global Atrial Septal Defect (ASD) Occluder Market Competitive Situation and Trends
2.8.1 Global Atrial Septal Defect (ASD) Occluder Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Atrial Septal Defect (ASD) Occluder Players Market Share by Revenue
2.8.3 Global Atrial Septal Defect (ASD) Occluder Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Atrial Septal Defect (ASD) Occluder Market Scenario by Region
3.1 Global Atrial Septal Defect (ASD) Occluder Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Atrial Septal Defect (ASD) Occluder Sales by Region: 2021–2032
3.2.1 Global Atrial Septal Defect (ASD) Occluder Sales by Region: 2021–2026
3.2.2 Global Atrial Septal Defect (ASD) Occluder Sales by Region: 2027–2032
3.3 Global Atrial Septal Defect (ASD) Occluder Revenue by Region: 2021–2032
3.3.1 Global Atrial Septal Defect (ASD) Occluder Revenue by Region: 2021–2026
3.3.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Region: 2027–2032
3.4 North America Atrial Septal Defect (ASD) Occluder Market Facts & Figures by Country
3.4.1 North America Atrial Septal Defect (ASD) Occluder Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Atrial Septal Defect (ASD) Occluder Sales by Country (2021–2032)
3.4.3 North America Atrial Septal Defect (ASD) Occluder Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Atrial Septal Defect (ASD) Occluder Market Facts & Figures by Country
3.5.1 Europe Atrial Septal Defect (ASD) Occluder Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Atrial Septal Defect (ASD) Occluder Sales by Country (2021–2032)
3.5.3 Europe Atrial Septal Defect (ASD) Occluder Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Atrial Septal Defect (ASD) Occluder Market Facts & Figures by Region
3.6.1 Asia Pacific Atrial Septal Defect (ASD) Occluder Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Atrial Septal Defect (ASD) Occluder Sales by Region (2021–2032)
3.6.3 Asia Pacific Atrial Septal Defect (ASD) Occluder Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Atrial Septal Defect (ASD) Occluder Market Facts & Figures by Country
3.7.1 Latin America Atrial Septal Defect (ASD) Occluder Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Atrial Septal Defect (ASD) Occluder Sales by Country (2021–2032)
3.7.3 Latin America Atrial Septal Defect (ASD) Occluder Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Atrial Septal Defect (ASD) Occluder Market Facts & Figures by Country
3.8.1 Middle East and Africa Atrial Septal Defect (ASD) Occluder Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Atrial Septal Defect (ASD) Occluder Sales by Country (2021–2032)
3.8.3 Middle East and Africa Atrial Septal Defect (ASD) Occluder Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Atrial Septal Defect (ASD) Occluder Sales by Type (2021–2032)
4.1.1 Global Atrial Septal Defect (ASD) Occluder Sales by Type (2021–2026)
4.1.2 Global Atrial Septal Defect (ASD) Occluder Sales by Type (2027–2032)
4.1.3 Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Type (2021–2032)
4.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Type (2021–2032)
4.2.1 Global Atrial Septal Defect (ASD) Occluder Revenue by Type (2021–2026)
4.2.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Type (2027–2032)
4.2.3 Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Type (2021–2032)
4.3 Global Atrial Septal Defect (ASD) Occluder Price by Type (2021–2032)
5 Segment by Application
5.1 Global Atrial Septal Defect (ASD) Occluder Sales by Application (2021–2032)
5.1.1 Global Atrial Septal Defect (ASD) Occluder Sales by Application (2021–2026)
5.1.2 Global Atrial Septal Defect (ASD) Occluder Sales by Application (2027–2032)
5.1.3 Global Atrial Septal Defect (ASD) Occluder Sales Market Share by Application (2021–2032)
5.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Application (2021–2032)
5.2.1 Global Atrial Septal Defect (ASD) Occluder Revenue by Application (2021–2026)
5.2.2 Global Atrial Septal Defect (ASD) Occluder Revenue by Application (2027–2032)
5.2.3 Global Atrial Septal Defect (ASD) Occluder Revenue Market Share by Application (2021–2032)
5.3 Global Atrial Septal Defect (ASD) Occluder Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Gore Medical
6.1.1 Gore Medical Company Information
6.1.2 Gore Medical Description and Business Overview
6.1.3 Gore Medical Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Gore Medical Atrial Septal Defect (ASD) Occluder Product Portfolio
6.1.5 Gore Medical Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Abbott Atrial Septal Defect (ASD) Occluder Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 Lepu Medical
6.3.1 Lepu Medical Company Information
6.3.2 Lepu Medical Description and Business Overview
6.3.3 Lepu Medical Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Lepu Medical Atrial Septal Defect (ASD) Occluder Product Portfolio
6.3.5 Lepu Medical Recent Developments/Updates
6.4 Lifetech
6.4.1 Lifetech Company Information
6.4.2 Lifetech Description and Business Overview
6.4.3 Lifetech Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Lifetech Atrial Septal Defect (ASD) Occluder Product Portfolio
6.4.5 Lifetech Recent Developments/Updates
6.5 Occlutech
6.5.1 Occlutech Company Information
6.5.2 Occlutech Description and Business Overview
6.5.3 Occlutech Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Occlutech Atrial Septal Defect (ASD) Occluder Product Portfolio
6.5.5 Occlutech Recent Developments/Updates
6.6 MicroPort Group
6.6.1 MicroPort Group Company Information
6.6.2 MicroPort Group Description and Business Overview
6.6.3 MicroPort Group Atrial Septal Defect (ASD) Occluder Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 MicroPort Group Atrial Septal Defect (ASD) Occluder Product Portfolio
6.6.5 MicroPort Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Atrial Septal Defect (ASD) Occluder Industry Chain Analysis
7.2 Atrial Septal Defect (ASD) Occluder Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Atrial Septal Defect (ASD) Occluder Production Mode & Process Analysis
7.4 Atrial Septal Defect (ASD) Occluder Sales and Marketing
7.4.1 Atrial Septal Defect (ASD) Occluder Sales Channels
7.4.2 Atrial Septal Defect (ASD) Occluder Distributors
7.5 Atrial Septal Defect (ASD) Occluder Customer Analysis
8 Atrial Septal Defect (ASD) Occluder Market Dynamics
8.1 Atrial Septal Defect (ASD) Occluder Industry Trends
8.2 Atrial Septal Defect (ASD) Occluder Market Drivers
8.3 Atrial Septal Defect (ASD) Occluder Market Challenges
8.4 Atrial Septal Defect (ASD) Occluder Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-06-16
Pages: 128
USD 3950.00
(Single User License)
The global Atrial Septal Defect (ASD) Occluder market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 79
USD 4250.00
(Single User License)
The global Atrial Septal Defect (ASD) Occluder market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 138
USD 4900.00
(Single User License)
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 95
USD 3950.00
(Single User License)
The global market for Atrial Septal Defect (ASD) Occluder was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-01-13
Pages: 80
USD 2900.00
(Single User License)
The atrial septal defect (ASD) occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
Published Date: 2024-04-13
Pages: 109
USD 4900.00
(Single User License)
The atrial septal defect (ASD) occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
Published Date: 2024-02-21
Pages: 88
USD 2900.00
(Single User License)
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published Date: 2024-01-09
Pages: 97
USD 3950.00
(Single User License)
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-06-16
Pages: 128
The global Atrial Septal Defect (ASD) Occluder market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 79
The global Atrial Septal Defect (ASD) Occluder market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 138
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 95
The global market for Atrial Septal Defect (ASD) Occluder was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-01-13
Pages: 80
The atrial septal defect (ASD) occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
Published: 2024-04-13
Pages: 109
The atrial septal defect (ASD) occluder is a percutaneous, transcatheter, atrial septal defect closure device intended for the occlusion of atrial septal defects (ASD) in secundum position or patients who have undergone a fenestrated Fontan procedure and who now require closure of the fenestration.
Published: 2024-02-21
Pages: 88
The global market for Atrial Septal Defect (ASD) Occluder was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
Published: 2024-01-09
Pages: 97
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now